Highlights from Wide-Ranging Interview with Atul Gawande, Head of the New ABJ (Amazon/Berkshire/JP Morgan Chase) Healthcare Endeavor, Provides Glimpse of Vision and What They Hope to Accomplish

(Note: In keeping with our 2 Minute Drill mantra, we’ve broken this into two parts. Today in Part 1 we’ll highlight Gawande’s view of the three big systemic problems with healthcare. Tomorrow in Part 2 we’ll summarize his vision for the ABJ-HCE.) Last week...

If You Want A Pragmatic Understanding of the Opioid Epidemic You May Want to Listen to This

This post follows up on last week’s primer on how abuse of prescription pain medications has led to what’s now recognized as a true national crisis. The new podcast Embedded provides a riveting inside look at how the use of one particularly powerful prescription...

Pain Meds and The Opioid Epidemic: 10 Things To Know

There’s a lot in the news these days about what’s referred to as the opioid crisis or epidemic. Just yesterday for instance —  highly respected healthcare consultant (and close friend) Joe Paduda, fresh off of speaking at a national drug summit in Atlanta, wrote...

New Source of Over-Utilization? Study Indicates Use of Retail Clinics May Be Increasing Healthcare Costs

Use of retail clinics leads to higher costs. Seems a bit counter-intuitive doesn’t it? You’d think that the use of retail clinics like those found in some CVS and Kroger stores and typically staffed by nurse practitioners would be apt to lower total costs. In fact...

Rx Shock: Ever Faced A 900% Increase Nearly Overnight? You’re Not Alone.

We are finding some crazy Rx trends that are translating into real world cost and care issues for our clients and their employees. Here’s a prime example. We recently found that a type 2 diabetes drug (GLUMETZA) increased in cost by 900%, nearly overnight. After...